These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment. Patelli F; Fasolino G; Radice P; Russo S; Zumbo G; DI Tizio FM; Frisone G; Marchi S Retina; 2005; 25(7):840-5. PubMed ID: 16205561 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide: valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular edema. Micelli Ferrari T; Sborgia L; Furino C; Cardascia N; Ferreri P; Besozzi G; Sborgia C Eur J Ophthalmol; 2004; 14(4):321-4. PubMed ID: 15309977 [TBL] [Abstract][Full Text] [Related]
7. [Triamcinolone in the treatment of the diabetic macular edema--one-year results]. Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654 [TBL] [Abstract][Full Text] [Related]
8. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK; Simpson JM; Gillies MC Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema. Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. Tewari HK; Sony P; Chawla R; Garg SP; Venkatesh P Eur J Ophthalmol; 2005; 15(5):619-26. PubMed ID: 16167293 [TBL] [Abstract][Full Text] [Related]
15. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Diabetic Retinopathy Clinical Research Network Ophthalmology; 2008 Sep; 115(9):1447-9, 1449.e1-10. PubMed ID: 18662829 [TBL] [Abstract][Full Text] [Related]
16. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Larsson J; Zhu M; Sutter F; Gillies MC Am J Ophthalmol; 2005 May; 139(5):802-6. PubMed ID: 15860283 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema. Margolis R; Singh RP; Bhatnagar P; Kaiser PK Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830 [TBL] [Abstract][Full Text] [Related]